Togo

in page functions
Total population (2013) 6,816,982
Birth cohort (2013) 248,334
Surviving Infants (surviving to 1 year per year, 2013) 231,991
Infant mortality rate (deaths < 1 year per 1000 births, 2012) 62/1000
Child mortality rate (deaths < 5 years per 1000 births, 2012) 96/1000
World Bank Index, IDA (2012) 2.89
Gross Nation Income (per capita US$, 2012) 500
Co-financing status (2013) Low-income
No. of districts/territories (2012) 35

GAVI support for Togo

Type of support

Approvals

2001-2017 (US$)
(31 Dec 2013)

Commitments

2001-2017 (US$)
(31 Dec 2013)

Disbursements

2000-2013 (US$)
(31 Dec 2013)

% Disbursed

(31 Dec 2013)
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
Civil Society Organisation support (CSO) $268,308 N/A
Health system strengthening (HSS) $3,674,000 $4,947,500 $2,425,000 66%
Immunisation services support (ISS) $2,990,600 $2,990,600 $2,952,900 99%
Injection safety support (INS) $317,617 $317,617 $317,617 100%
Penta (NVS) $12,006,444 $13,793,444 $11,872,098 99%
Pneumo (NVS) $5,123,500 $8,847,500 $2,477,907 48%
Rotavirus (NVS) $1,773,000 $3,233,500 $1,469,740 83%
Vaccine Introduction Grant $650,500 $650,500 $200,000 31%
Yellow Fever (NVS) $2,025,388 $2,331,388 $1,881,811 93%
Total $28,561,050 $37,112,050 $23,865,380

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the GAVI Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Togo DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2012)

Grade of confidence
84%

*
DTP3 - Official country estimates (2012) 84%
M:F sex ratio at birth (2013) 1.02
Household survey: DTP3 coverage for male (2010) 70.60%
Household survey: DTP3 coverage for female (2010) 74.30%
Household survey: Last DTP3 survey (2010) 72%
% districts achieving > 80% DTP3 coverage (2012) 89%
% districts achieving < 50% DTP3 coverage (2012) 0%
MCV WHO/UNICEF estimates (2012) 72%
Polio WHO/UNICEF estimates (2012) 84%

Breakdown of support

Non-vaccine support Vaccine support
26% 74%
$6,163,824 $17,701,553

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Togo

23 April 2014

WIW 2014 En

GAVI Alliance to present plans to expand impact of vaccines by 2020

Drive to secure a healthy future for children in developing countries.

04 February 2014

HPV vaccine with GAVI support

206,000 more girls to benefit from HPV vaccine with GAVI Alliance support

10 countries approved in latest round of HPV vaccine demonstration programmes.

21 February 2012

Nigeria MenA

Q and A on Nigeria’s introduction of MenAfriVac

Interview with Muhammad Sani Adamu, Head of Accelerated Disease Control in Nigeria’s National Primary Health Care Development Agency, who played a key role in rolling out the new vaccine against meningitis A, MenAfriVac, to Nigeria’s northern states.

close icon

modal window here